Profil
Steven A. Cantor is the founder of Vaso Corp.
and bioAffinity Technologies, Inc. He previously worked as the Manager of Business Development at Neurox Pharmaceuticals LLC from 2011 to 2014, Co-Chief Executive Officer & Director at enVVeno Medical Corp.
from 2017 to 2018, and Chairman at Crown Equity Holdings, Inc. in 2018 to 2019.
Tidigare kända positioner av Steven Cantor
| Företag | Position | Slut |
|---|---|---|
| CROWN EQUITY HOLDINGS INC. | Ordförande | 2019-01-09 |
| ENVVENO MEDICAL CORPORATION | Verkställande Direktör | 2018-04-01 |
| BIOAFFINITY TECHNOLOGIES, INC. | Grundare | 2014-05-01 |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Företagsledare/Principal | 2014-01-01 |
| VASO CORPORATION | Verkställande Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Vaso Corp.
Vaso Corp. Information Technology ServicesTechnology Services Engages in the healthcare equipment and information technology industries | Technology Services |
enVVeno Medical Corp.
enVVeno Medical Corp. Medical SpecialtiesHealth Technology Specializes in biological cardiovascular implants | Health Technology |
Crown Equity Holdings, Inc.
Crown Equity Holdings, Inc. Advertising/Marketing ServicesCommercial Services Operates as a holding company whose subsidiaries provides computer related services | Commercial Services |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
















